SAN MATEO, Calif. — Survey results released today in time for the American Academy of Pediatrics 2004 National Conference & Exhibition show significant positive impact on quality of care from use of PDAs in pediatric practice.
Seventy-five percent of survey respondents use their PDA more than six times per day, most often to access drug information (96%). Most significantly, 80% of respondents said they practice safer medicine using a PDA, while nearly two-thirds said that using their PDA had decreased the number of potential medical errors. These results are comparable to findings in previous studies among other physician PDA users, including a study conducted by Harvard Medical School.
“The survey results show that handheld access to drug and clinical references at the point-of-care is improving the quality of care for our children. It is clear that Epocrates is playing a key role in today’s pediatrics practice,” said Kirk Loevner, CEO, Epocrates.
The survey of more than 400 pediatricians who subscribe to handheld clinical reference applications from Epocrates was conducted during September 2004 and was designed to collect their thoughts on everything from how the PDA has changed their practice to childhood obesity, one of the AAP conference themes. The survey has a five percent margin of error.
In addition to researching pediatrician’s views on this subject, Epocrates launched a DocAlert messaging campaign to the nearly 130,000 pediatricians, family and nurse practitioners and medical students who subscribe to Epocrates handheld clinical references.
Through DocAlert(R) technology, clinicians receive up to three brief and timely messages specific to pediatricians when syncing their PDA, and are able to request additional information via e-mail. This is just one of the many pediatrician-friendly features in Epocrates Essentials, including
- More than 1,200 disease and condition monographs (with direct links to drug monographs)
- Brand and generic drug monographs with pediatric dosing
- Diagnostic and drug interaction information
- An integrated weight-based dosing calculator and BMI, BEE, and Pediatric Maintenance Fluids calculators
- An infectious disease treatment guide including substantial pediatric ID content
- More than 70 tables including PALS guidelines, Apgar Score and pediatric vaccination schedules
About Epocrates, Inc.
San Mateo, CA-based Epocrates Inc. is the leader in providing clinical information to physicians and other health care professionals at the point of care, with over 420,000 subscribers, including over 165,000 U.S. physicians. Epocrates’ product offering is led by the Epocrates(R) Essentials mobile clinical reference suite featuring all of the key decision support applications — drugs, diseases, and diagnostics — required for today’s health care professional.
The Epocrates Rx(R) and Epocrates Rx Pro(TM) drug reference products are the most widely used in the industry, by individual clinicians and by medical groups, hospitals, universities and medical libraries throughout the U.S. Epocrates also provides formulary information from health plans, hospitals, Medicaid agencies and pharmacy benefit management (PBM) companies that represent over 95 million individuals, and messaging, market research and clinical trial recruitment services.
For more information, visit http://www.epocrates.com.